Table 1.
N a | Genetics variantsb | No. of pigs per group | Weaning | Conditioning | ETECc | Challenge dose | Challenge timingd | Control groupe | Indicators for challenge effectiveness | End of the trial | Reff |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | MUC4 −/− +/− and +/+ | 8 | d28 | No | F4ac | 109 CFU/mL | 3 dpw | NA | NA | 7 dpi | [67] |
2 | MUC4 −/− | 8 | d21 | No | F4ac | 10 mL of ETEC culture 109 CFU/mL | 8 dpw | Neg | Diarrhea; RTi | 7 dpi | [70] |
3 | MUC4 −/− | 6 | d21 | No | F4ac | 10 mL of ETEC culture 109 CFU/mL | 8 dpw | Neg | Diarrhea; RTi | 7 dpi | [69] |
4 | MUC4 −/− | 8 | d21 | No | F4ac | 1 × 1010 CFU/mL | 8 dpw | Neg | Abundance of E.coli in feces | 7 dpi | [68] |
5 | MUC4 +/+ | 10 | d24 | No | F4ac | 5 mL of suspension containing 108 CFU/mL | 7 dpw | NA | Diarrhea; fecal ETEC plate counts; anti-F4 IgA and IgM in blood | 14 dpi | [12] |
6 | MUC4 +/+ | 5 | d24 | No | F4ac | 5 mL of suspension containing 108 CFU/mL | 7 dpw | NA | Diarrhea; In vitro adhesion test | 24 h pi | [44] |
7 | MUC4 +/+ | 10 or 20 | d17–18 | Yes | F4ac | 1.5 × 109 CFU/mL or 1.7 × 109 CFU/mL or 9.8 × 108 CFU/mL | 3 or 7 or 21 dpw | NA | Diarrhea; gut content consistency; ETEC F4 fecal shedding; serum and intestinal anti-F4 IgM, IgA and IgG | 3 or 5 dpi | [14] |
8 | MUC4+/+ | 8 | d42 | Yes | F4ac |
1 × 108 CFU in 20 mL NaCl |
From 1 to 3 dpw | Neg | Diarroea; fecal ETEC plate counts, IgA and IgM in blood | 10 dpw | [64] |
9 | MUC4+/+ | 6 | d28 | Yes | F4ac |
1 × 108 CFU in 20 mL NaCl |
From 1 to 2 | Neg | Diarroea; fecal ETEC plate counts | 12 dpw | [65] |
10 |
van Haeringen laboratory MUC4+/+. |
gExp1 = 3; gExp2 = 6 | d28 | Yes | F4ac | 1 × 109 CFU/mL in 5 mL of 9% NaCl + 10 mL of 10% NaHCO3 | 2 dpw | Exp1: Neg; Exp2: NA | gExp1 and Exp2: Diarrhea and fecal DM; fecal haemolic E. coli; | 19 dpi | [91] |
11 |
van Haeringen laboratory MUC4+/+ |
8–10 | d30–32 | Yes | F4ac |
5 × 107 CFU in 20 mL NaCl |
From 1 to 2 dpw | Neg | Diarroea; fecal ETEC plate counts | 10 dpw | [15] |
12 | MUC13 +/+ | gExp1 = 16; gExp2 = 18 | d24 | No | F4ac | 5 mL of 108 CFU/ mL | 4 dpw | Neg | gExp1: Diarrhea; Exp2: Diarrhea; fecal ETEC quantification | 13 dpi | [46] |
13 | MUC4 +/+; FUT1 +/+ |
F4 = 20; F18 = 18 |
d28 | Yes | F4 and F18ac | F18ac: 1011 CFU/mL; F4 1011 CFU/mL for 2 days | 7 dpw | Neg | Diarrheal; ETEC F18 and F4 fecal shedding; F18 and F4 specific antibodies in blood; in vitro adhesion test | 20 dpi | [72] |
14 | Exp1:FUT1 +/+ and MUC4 −/− or MUC4 +/+; Exp2: FUT1 +/+ and MUC4 +/+ | gExp1 = 12; gExp2 = 10 | d16–18 | No | gExp1:F18; gExp2:F4 | Exp1 = 1 × 1010 CFU/mL or 5 × 1010 CFU/mL; Exp2 = 1.3 × 109 CFU/mL | 7 or 21 d post vaccination | Neg | Diarrhea; ETEC F18 and F4 fecal shedding; Serum anti-F4 and anti-F18 IgM and IgA; | Exp1 = 7 dpi; Exp2 = 4 dpi | [66] |
15 | MUC4 +/+ and FUT1 +/+ | 6 | NA | No | F18ab | 10 mL of 1011 CFU/ mL | 62 dpw | NA | Fecal ETEC F18; serum IgA; in vitro adhesion test | 7 dpi | [73] |
16 | FUT1 +/+ | 6 | gExp1: d25; gExp2: d30 | Yes |
gExp1: F18ab; gExp2:F18ac |
gExp1: 5 mL of 6.7 log CFU; gExp2: 5 ml of 6.7 log CFU | Exp1: 11 dpw; Exp2: 13 dpw + 30 dpw the 2° challenge | NA | ETEC F18 fecal count; serum F18 IgA | 8 dpi | [113] |
17 | FUT1 +/+ | gExp1 = 4; gExp2 = 3 | d28 | Yes | F18ab | 10 mL of 1011 CFU/ mL | at weaning | NA | Diarrhea; F18-specific antibodies in blood; in vitro adhesion test | 8 dpi | [47] |
18 | FUT1 +/+ | 9 | Not pertinenth | No | F18 | 1 mL of 7.5 × 1010 CFU/ mL | from days 1–8 of life | Neg | Diarrhea; E. coli aboundance in intestinal content | 8 dpi | [75] |
19 | FUT1 +/+ | 10 | Not pertinenth | No | F18 | 1 mL of 1010 CFU/ mL | from days 1–4 of life | Neg | Diarrhea | 5 dpi | [76] |
20 | FUT1 +/+ |
gExp1 = 6; gExp2 = 5 |
gExp1 = d28; gExp2 = d21 | F18 | 10 mL of 1011 CFU/ mL | gExp1: 22 dpw; gExp2: 7 dpw | Exp1: Neg; Exp2: NA | gExp1and Exp 2: Fecal excretion of ETEC F18; F18- and FedF-specific IgM, IgA and IgG response in blood and saliva; in vitro adhesion test | Exp1:18 dpi; Exp2:21 dpi | [74] | |
21 | FUT1 +/+ | 18 | d28–34 | No | F18 | 50 mL of 3 × 108 CFU/ mL | From 3 to 6 dpw | NA | Diarrhea; E. coli and Hemolytic bacteria count on feces; Fecal DM; plasma IgA and IgG | Not reported | [17] |
aN Study number
bGenetics variants: MUC4:Mucine4; MUC13:Mucine13; FUT1: Fucosyltransferase 1. +/+ stands for the genotypes associated with the susceptibility to the respective ETEC; −/−: the genotypes associated with the resistance
cETEC Enterotoxigenic Escherichia coli
dChallenge timing: it was reported as days post-weaning (dpw)
eControl group: Neg Negative control group (not infected), Pos Positive control group (group treated with antibiotic)
fRef. Reference
gExp Experiment
hNot pertinent: performed in newborn cesarean-delivered pigs
iRT Rectal temperature
Additional abbreviations: D day, CFU Colony forming units, NA Not available, dpi Days post-inoculum